Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma

類似資料

• Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma
  著者:: Brioli, Annamaria, 等
  出版事項: (2014)
• Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents
  著者:: Tacchetti, Paola, 等
  出版事項: (2017)
• Treatment optimization for multiple myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in in vitro and ex vivo models
  著者:: Borsi, Enrica, 等
  出版事項: (2018)
• Role of Imaging in the Evaluation of Minimal Residual Disease in Multiple Myeloma Patients
  著者:: Zamagni, Elena, 等
  出版事項: (2020)
• Daratumumab in dialysis-dependent multiple myeloma
  著者:: Jeyaraman, Preethi, 等
  出版事項: (2020)